SCHEMBL15065396

SCHEMBL15065396

CCOC(=O)C=Cc1ccc(OC)cc1Oc1cccc(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.53
▸ ALDH1A1 P00352 5/20 0.53
▸ KDM4E B2RXH2 4/20 0.53
▸ LMNA P02545 3/20 0.53
▸ HPGD P15428 3/20 0.53
▸ ESR1 P03372 1/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ NPC1 O15118 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ HSD17B1 P14061 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ HSD17B2 P37059 1/20 0.47
▸ HDAC8 Q9BY41 1/20 0.47
▸ GLA P06280 1/20 0.46
▸ GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15065394 1.00 MAPT (0.53) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL15065953 0.88 LMNA (0.53) MAPTALDH1A1LMNAESR1HSD17B1
SCHEMBL15065954 0.88 LMNA (0.53) MAPTALDH1A1LMNAESR1HSD17B1
SCHEMBL15066478 0.85 LMNA (0.71) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL15066479 0.85 LMNA (0.71) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL4592405 0.82 MAPT (0.68) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL4592398 0.82 MAPT (0.68) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL15066339 0.81 MAOB (0.45) ALDH1A1LMNAHDAC8SMN1; SMN2
SCHEMBL15066340 0.81 MAOB (0.45) ALDH1A1LMNAHDAC8SMN1; SMN2
SCHEMBL25288435 0.80 HDAC8 (0.58) MAPTALDH1A1KDM4EESR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS LLC 2015-02-12 — — US disclosed
EP-2797875-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 Pharmacyclics, Inc. (US) 2014-11-05 — — EP disclosed
WO-2013101600-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 PHARMACYCLICS, INC. (US) 2013-07-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150045367-A1 CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8 HDAC8, HDAC5, HDAC7 MAPT 2192/4885ALDH1A1 688/4885KDM4E 781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback